Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Johnsen
SAT0468 Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients With Active Psoriatic Arthritis: Results From a Post Hoc Analysis From a Phase Iii Study
Related publications
Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial
Arthritis Research & Therapy
Response To: “A Somatization Comorbidity Phenotype Impacts Response to Therapy in Rheumatoid Arthritis: Post Hoc Results From the Certolizumab Pegol Phase 4 PREDICT Trial”
Arthritis Research & Therapy
Longterm (52-Week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients With Psoriatic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients With Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan
Journal of Clinical Sleep Medicine
Pulmonary
Neurology
Respiratory Medicine
AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies
The Effect of Psoriatic Arthritis on Ixekizumab Clinical Outcomes in Moderate-To-Severe Psoriasis Patients: A Post Hoc Analysis
Journal of the American Academy of Dermatology
Dermatology
Exploratory Study to Identify Mechanical Factors That May Contribute to Toe Dactylitis in Patients With Psoriatic Arthritis
Journal of Foot and Ankle Research
Orthopedics
Sports Medicine
Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study
Arthritis Care and Research
Rheumatology
A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study
Arthritis Research & Therapy
